Developer of cell encapsulation and transplantation technology for therapeutic applications. The company's technology is based on encapsulation research conducted at Brown University and pancreas islet cell isolation research conducted at Washington University in St. Louis. The company's first product consists of dopamine-secreting encapsulated mouse cells for treating Parkinson's disease. The second product is encapsulated porcine pancreatic islet cells for treating insulin-dependent diabetes.
Cytotherapeutics Headquarter Location
Two Richmond Square
Providence, Rhode Island, 02906,
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing Cytotherapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cytotherapeutics is included in 1 Expert Collection, including Diabetes.